# Effect of Dotinurad in Hyperuricemia With Hypertension

> **NCT06834230** · PHASE4 · RECRUITING · sponsor: **Saga University** · enrollment: 360 (estimated)

## Conditions studied

- Hyperuricemia or Gout
- Hypertension

## Interventions

- **DRUG:** Dotinurad
- **DRUG:** Febuxostat

## Key facts

- **NCT ID:** NCT06834230
- **Lead sponsor:** Saga University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-28
- **Primary completion:** 2027-07-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06834230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06834230, "Effect of Dotinurad in Hyperuricemia With Hypertension". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06834230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*